Dr. Robert Saenz, MD

NPI: 1669446829
Total Payments
$1,591
2023 Payments
$173.39
Companies
6
Transactions
7

Payment Breakdown by Category

Consulting$1,140 (71.6%)
Food & Beverage$451.38 (28.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $1,140 1 71.6%
Food and Beverage $451.38 6 28.4%

Top Paying Companies

Company Total Records Latest Year
Novartis Pharmaceuticals Corporation $1,140 1 $0 (2020)
Allergan Inc. $197.81 2 $0 (2019)
BIOTISSUE HOLDINGS, INC. $173.39 1 $0 (2023)
Kala Pharmaceuticals, Inc. $39.44 1 $0 (2020)
Sight Sciences, Inc. $21.02 1 $0 (2022)
Dompe US, Inc. $19.72 1 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2023 $173.39 1 BIOTISSUE HOLDINGS, INC. ($173.39)
2022 $40.74 2 Sight Sciences, Inc. ($21.02)
2020 $1,179 2 Novartis Pharmaceuticals Corporation ($1,140)
2019 $87.26 1 Allergan Inc. ($87.26)
2018 $110.55 1 Allergan Inc. ($110.55)

All Payment Transactions

7 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
04/17/2023 BIOTISSUE HOLDINGS, INC. PROKERA (Device), AMNIOGRAFT Food and Beverage In-kind items and services $173.39 General
Category: HUMAN TISSUE PRODUCTS
07/08/2022 Dompe US, Inc. OXERVATE (Drug) Food and Beverage In-kind items and services $19.72 General
Category: SOLUTION/ DROPS
05/26/2022 Sight Sciences, Inc. TearCare SmartLid (Device), TEARCARE(TM) (2.2) SYSTEM KIT Food and Beverage In-kind items and services $21.02 General
Category: Ophthalmology
12/02/2020 Novartis Pharmaceuticals Corporation XIIDRA (Drug) Consulting Fee Cash or cash equivalent $1,140.00 General
Category: OPHTHALMOLOGY
03/07/2020 Kala Pharmaceuticals, Inc. INVELTYS (Drug) Food and Beverage In-kind items and services $39.44 General
Category: OCULAR
08/21/2019 Allergan Inc. LUMIGAN (Drug) Food and Beverage In-kind items and services $87.26 General
Category: OPHTHALMOLOGY
07/03/2018 Allergan Inc. RESTASIS (Drug) Food and Beverage In-kind items and services $110.55 General
Category: DRY EYE

About Dr. Robert Saenz, MD

Dr. Robert Saenz, MD is a Anatomic Pathology & Clinical Pathology healthcare provider based in Fort Worth, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669446829.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Saenz, MD has received a total of $1,591 in payments from pharmaceutical and medical device companies, with $173.39 received in 2023. These payments were reported across 7 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($1,140).

Practice Information

Products in Payments

  • XIIDRA (Drug) $1,140
  • PROKERA (Device) $173.39
  • RESTASIS (Drug) $110.55
  • LUMIGAN (Drug) $87.26
  • INVELTYS (Drug) $39.44
  • TearCare SmartLid (Device) $21.02
  • OXERVATE (Drug) $19.72

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Anatomic Pathology & Clinical Pathology Doctors in Fort Worth